Monitor voting results for the shareholder proposal on political contributions, as significant opposition to management's position could signal governance concerns. The routine nature of the other proposals suggests minimal market impact.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 30 $284.79entry
- T+1 · 8mo ago +2.79%α −0.10% · $292.75
- T+5 · 7mo ago +9.49%α +5.19% · $311.83
- T+20 · 7mo ago +27.37%α +14.77% · $362.74
- T+60 · 5mo ago +36.00%α +19.51% · $387.32
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Elevance Health is holding its 2026 annual shareholder meeting to vote on director elections, executive compensation, auditor ratification, and a shareholder proposal regarding political contributions. The board recommends voting for its nominees and against the shareholder proposal.
Key Financial Metrics
Key Facts
- Annual shareholder meeting scheduled for May 13, 2026
- Proposals include election of three directors (Gail K. Boudreaux, Robert L. Dixon, Jr., Deanna D. Strable)
- Advisory vote on executive compensation (Say-on-Pay)
- Ratification of Ernst & Young LLP as auditors
- Shareholder proposal requesting study on corporate political contributions
- Board recommends voting FOR director elections, executive compensation, and auditor ratification
- Board recommends voting AGAINST the shareholder political contributions proposal
Financial Impact
No immediate financial impact expected from this proxy filing
Risk Factors
- Potential governance concerns if the shareholder proposal receives strong support despite management opposition
- Limited immediate financial impact from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001156039-26-000032 |
| Document: 0001156039-26-000032-index-headers.html | 0001156039-26-000032 |
| Document: 0001156039-26-000032-index.html | 0001156039-26-000032 |
| Document: 0001156039-26-000032.txt | 0001156039-26-000032 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers